”I am excited to join the impressive Medical Advisory Board of uBiome. The more we learn about the microbiome, the more excited I am about its medical, health, and wellness implications and potential applications.” - Dr. Donnica Moore, MD
SAN FRANCISCO (PRWEB) October 26, 2018
uBiome, the leader in microbial genomics, announces the addition of Dr. Donnica Moore, MD, President of Sapphire Women’s Health Group and prominent women’s health expert, to its Medical Advisory Board. Joining the board of leading scientists and doctors from around the world, Dr. Moore will bring to uBiome her expertise on women’s health including risk factors for chronic and common conditions. The appointment will help uBiome continue its advancement in human microbiome research.
“For decades, Dr. Moore has been a leading figure in the public sphere to bring women’s health issues to the forefront,” Dr. Jessica Richman, PhD, co-founder and CEO of uBiome, said. “She is a gifted educator and advocate for women, and we are honored to have her as a new member of uBiome’s Medical Advisory Board.”
Dr. Moore earned her medical degree from the State University of New York at Buffalo School of Medicine. She undertook residency training in obstetrics and gynecology at Temple University Hospital and in family medicine at Memorial Hospital of Burlington County (NJ). Dr. Moore currently hosts the podcast “In the Ladies’ Room with Dr. Donnica,” and she is the author of “Women's Health for Life.” Previously, Dr. Moore served as a women's health contributor for NBC's Later Today, appearing weekly from 1999-2000 and covering diverse women's health issues. Dr. Donnica has appeared on more than 875 television interviews including ABC’s Good Morning America, ABC's The View, The Today Show, The Dr. Oz Show, and NBC's Weekend Today Show. She has also hosted a nationally syndicated radio spot, “Dr. Donnica's Women's Health Report.” Honors include being named One of the Most Influential Forces in Healthcare Information Technology (2000) from Advance for Healthcare Technology magazine, Top 25 Leading Women Entrepreneurs (2017) from Leading Women Entrepreneurs, and Award for Excellence in Alumni Education from Princeton University (2013), among others.
About joining uBiome's Medical Advisory Board, Dr. Moore said, ”I am excited to join the impressive Medical Advisory Board of uBiome. The more we learn about the microbiome, the more excited I am about its medical, health, and wellness implications and potential applications.”
In addition to Dr. Moore, the uBiome Advisory Board also includes Dr. Joseph DeRisi (MacArthur Genius and UCSF professor), Dr. Atul Butte (head of the Institute for Computational Health Sciences at UCSF), Dr. Katherine Pollard (Director, Gladstone Institute for Data Science and Biotechnology), Dr. Joel Palefsky (UCSF School of Medicine professor), Dr. George Church (leading geneticist at Harvard University), Dr. Liz Lipski (Academic Director of Nutrition and Integrative Health Programs at Maryland University of Integrative Health), Dr. Elaine Hsiao, PhD (UCLA), and other leading scientists. The company’s Medical Advisory Board includes Dr. Alan Green (Society for Participatory Medicine), Dr. Leo Treyzon (Cedars-Sinai Medical Center), Dr. Cynthia Geyer (Medical Director of Canyon Ranch, Lenox), Dr. Robynne Chutkan (Georgetown University Hospital), Michael Docktor (Boston Children’s Hospital), Dr. Tiffany Lester (Medical Director of Parsley Health in San Francisco), Dr. Joel Kahn (Founder of of the Kahn Center for Cardiac Longevity), as well as other accomplished clinicians.
Founded in 2012, uBiome is the leader in microbial genomics. The Company’s mission is to advance the science of the microbiome and make it useful to people. uBiome combines its patented proprietary precision sequencing™ with machine learning and artificial intelligence to develop wellness products, clinical tests, and therapeutic targets.
uBiome’s commercial products include SmartGut™, the world’s first sequencing-based clinical microbiome test, which identifies microbes in the gut for patients with chronic gut conditions such as IBD, IBS, Crohn’s Disease, and ulcerative colitis; SmartJane™, the first sequencing-based women’s health screening test, which genotypes all 19 clinically relevant strains of HPV, identifies four common STDs, and surveys more than 20 vaginal microbes associated with bacterial vaginosis and other conditions; and Explorer™, a health and wellness product to understand the role that food and lifestyle can play in wellness.
uBiome’s platform has been used by hundreds of thousands of consumers, patients, and doctors and more than 200 research institutions around the world, including the US Centers for Disease Control (CDC), US National Institutes of Health (NIH), Harvard University, Stanford University, the Massachusetts Institute of Technology (MIT), University of California, San Francisco, Oxford University, and the University of Sydney.
Since its launch, the company has received widespread recognition including CNN 10: Startups to Watch, the IVY Technology Award, CNN Future 30, and was named one of Fast Company’s Most Innovative Companies in Healthcare in 2016 and in Data Science in 2018, as well as a Technology Pioneer from the World Economic Forum in 2018. For more information, visit http://www.uBiome.com.